,i #aadth ,,congress #ast ,session ,h4 ,r4 #cfhj ,,in ,,the ,,house ,,of ,,representatives ,october #a1 #bjae ,mr4 ,sarbanes introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to provide for the ,secretary of ,health and ,human ,services to carry out a grant program for co-prescribing opioid overdose reversal drugs4 #a4 ,short title ,this ,act may be cited as the ,co-,prescribing to ,reduce ,overdoses ,act of #bjae4 #b4 ,co-prescribing opioid overdose reversal drugs grant program 7a7 ,establishment 7#a7 ,in general ,not later than six months after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services shall establish1 in accordance with this section1 a four-year co-prescribing opioid overdose reversal drugs grant program 7in this ,act referred to as the grant program7 under which the ,secretary shall provide not more than a total of #ab grants to eligible entities to carry out the activities described in subsection 7c74 7#b7 ,maximum grant amount ,a grant made under this section may not be for more than #bjj1jjj per grant year4 7#c7 ,eligible entity ,for purposes of this section1 the term eligible entity means a federally qualified health center 7as defined in section #ahfa7;aa7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7aa771 an opioid treatment program under part #h of title #db1 ,code of ,federal ,regulations1 or section #cjc7;g7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;g771 or any other entity that the ,secretary deems appropriate4 7#d7 ,co-prescribing ,for purposes of this section and section #c1 the term co-prescribing means1 with respect to an opioid overdose reversal drug1 the practice of prescribing such drug in conjunction with an opioid prescription for patients at an elevated risk of overdose1 or in conjunction with an opioid agonist approved under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 for the treatment of opioid abuse disorders1 or in other circumstances in which a provider identifies a patient at an elevated risk for an intentional or unintentional drug overdose from heroin or prescription opioid therapies4 ,for purposes of the previous sentence1 a patient may be at an elevated risk of overdose if the patient meets the criteria under the existing co-prescribing guidelines that the ,secretary deems appropriate1 such as the criteria provided in the ,opioid ,overdose ,toolkit published by the ,substance ,abuse and ,mental ,health ,services ,administration4 7b7 ,application ,to be eligible to receive a grant under this section1 an eligible entity shall submit to the ,secretary of ,health and ,human ,services1 in such form and manner as specified by the ,secretary1 an application that describes-- 7#a7 the extent to which the area to which the entity will furnish services through use of the grant is experiencing significant morbidity and mortality caused by opioid abuse2 7#b7 the criteria that will be used to identify eligible patients to participate in such program2 and 7#c7 how such program will work to try to identify ,state1 local1 or private funding to continue the program after expiration of the grant4 7c7 ,use of funds ,an eligible entity receiving a grant under this section may use the grant for any of the following activities3 7#a7 ,to establish a program for co-prescribing opioid overdose reversal drugs1 such as naloxone4 7#b7 ,to train and provide resources for health care providers and pharmacists on the co-prescribing of opioid overdose reversal drugs4 7#c7 ,to establish mechanisms and processes for tracking patients participating in the program described in paragraph 7#a7 and the health outcomes of such patients4 7#d7 ,to purchase opioid overdose reversal drugs for distribution under the program described in paragraph 7#a74 7#e7 ,to offset the co-pays and other cost sharing associated with opioid overdose reversal drugs to ensure that cost is not a limiting factor for eligible patients4 7#f7 ,to conduct community outreach1 in conjunction with community-based organizations1 designed to raise awareness of co-prescribing practices1 and the availability of opioid overdose reversal drugs4 7#g7 ,to establish protocols to connect patients who have experienced a drug overdose with appropriate treatment1 including medication assisted treatment and appropriate counseling and behavioral therapies4 7d7 ,evaluations by recipients ,as a condition of receipt of a grant under this section1 an eligible entity shall1 for each year for which the grant is received1 submit to the ,secretary of ,health and ,human ,services information on appropriate outcome measures specified by the ,secretary to assess the outcomes of the program funded by the grant1 including-- 7#a7 the number of prescribers trained2 7#b7 the number of prescribers who have co-prescribed an opioid overdose reversal drugs to at least one patient2 7#c7 the total number of prescriptions written for opioid overdose reversal drugs2 7#d7 the percentage of patients at elevated risk who received a prescription for an opioid overdose reversal drug2 7#e7 the number of patients reporting use of an opioid overdose reversal drug2 and 7#f7 any other outcome measures that the ,secretary deems appropriate4 7e7 ,reports by ,secretary ,for each year of the grant program under this section1 the ,secretary of ,health and ,human ,services shall submit to the appropriate ,committees of the ,house of ,representatives and of the ,senate a report aggregating the information received from the grant recipients for such year under subsection 7d7 and evaluating the outcomes achieved by the programs funded by grants made under this section4 #c4 ,opioid overdose reversal co-prescribing guidelines 7a7 ,in general ,the ,secretary of ,health and ,human ,services shall establish a grant program under which the ,secretary shall award grants to eligible ,state entities to develop opioid overdose reversal co-prescribing guidelines4 7b7 ,eligible ,state entities ,for purposes of subsection 7a71 eligible ,state entities are ,state departments of health in conjunction with ,state medical boards2 city1 county1 and local health departments2 and community stakeholder groups involved in reducing opioid overdose deaths4 7c7 ,administrative provisions 7#a7 ,grant amounts ,a grant made under this section may not be for more than #bjj1jjj per grant4 7#b7 ,prioritization ,in awarding grants under this section1 the ,secretary shall give priority to eligible ,state entities which propose to base their guidelines on existing guidelines on co-prescribing to speed enactment1 including guidelines of-- 7,a7 the ,department of ,veterans ,affairs2 7,b7 nationwide medical societies1 such as the ,american ,society of ,addiction ,medicine or ,american ,medical ,association2 and 7,c7 the ,centers for ,disease ,control and ,prevention4 #d4 ,authorization of appropriations ,there is authorized to be appropriated to carry out this ,act #d1jjj1jjj for each of fiscal years #bjaf through #bjbj4